Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01314326 · ClinicalTrials.gov registry record
Advanced Imaging for Glaucoma Study
A clinical trial, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- 832
- Enrollment target
NCT01314326 is a clinical trial that has completed, run by Oregon Health and Science University. The registered enrollment target is 832 participants.
The verdict
NCT01314326 has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- 832 participants
- Enrollment target
Study Summary
The specific aims of the clinical studies are to: 1. Predict the development of glaucomatous visual field (VF) abnormality in glaucoma suspects and pre-perimetric glaucoma patients based on anatomic abnormalities detected by advanced imaging. 2. Predict the development of glaucomatous VF abnormality in glaucoma suspects and pre-perimetric glaucoma patients based on anatomic changes detected between successive advanced imaging tests. 3. Determine the sensitivity and specificity of glaucoma diagnosis based on advanced imaging tests.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 832 participants |
| Start Date | 2003-09 |
| Est. Completion | 2015-05-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01314326
The ClinicalTrials.gov registry entry for NCT01314326 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 832 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01314326 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01314326 about?
NCT01314326 is a clinical study titled "Advanced Imaging for Glaucoma Study". The specific aims of the clinical studies are to: 1. Predict the development of glaucomatous visual field (VF) abnormality in glaucoma suspects and pre-perimetric glaucoma patients based on anatomic abnormalities detected by advanced imaging. 2. Predict the development of glaucomatous VF abnormalit...
What is the current status of trial NCT01314326?
This trial is currently completed. The enrollment target is 832 participants. The study started on 2003-09. Estimated completion is 2015-05-15.
Who is sponsoring clinical trial NCT01314326?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.